Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00063895 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00034879 | Iressa Expanded Access Program (EAP) | completed | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Jan 4, 2013 | clinicaltrials |
| Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma |
| completed |
| Phase 2 |
| 40 |
| Schwartzberg, Lee, M.D.INDIV |
| 1 |
| Dec 27, 2012 |
| clinicaltrials |
| NCT01755923 | Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01749072 | Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 120 | Peking Union Medical College HospitalOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00379665 | Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy | completed | Phase 2 | 25 | Southwestern Regional Medical CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00891579 | Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations | completed | Phase 2 | 161 | Chinese Society of Lung CancerOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01746277 | Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00132665 | Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301) | completed | Phase 3 | 200 | Japan Clinical Oncology GroupOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT01071434 | Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors | terminated | — | 5 | Stanford UniversityOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT00173888 | Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01742767 | Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC(PemSplitCisp) | unknown | Phase 2 | — | Universität Duisburg-EssenOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT01004510 | Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer(ZAP) | terminated | Phase 2 | 3 | Peter Bushunow MDOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | completed | Phase 1 / Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 27, 2012 | clinicaltrials |
| NCT01359436 | e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer | unknown | N/A | 200 | National Taiwan University HospitalOTHER | 1 | Nov 15, 2012 | clinicaltrials |
| NCT01466647 | A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) | completed | Phase 1 | 12 | Axelar ABINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01560195 | A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy | unknown | Phase 3 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 6, 2012 | clinicaltrials |
| NCT01717105 | Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients | unknown | — | 225 | Grupo Gallego de Cancer de PulmonOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT01079520 | Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 138 | Samsung Medical CenterOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 26 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00840125 | Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment | completed | Phase 2 | 4 | Meir Medical CenterOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01124812 | 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 3 | Philogen S.p.A.INDUSTRY | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00702182 | Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | National Cancer Centre, SingaporeOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01385111 | Combined Application of EBUS and EUS in Lung Cancer | completed | N/A | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 18, 2012 | clinicaltrials |
| NCT01218594 | Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer(DP-EN-RT) | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00095199 | Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 15, 2012 | clinicaltrials |
| NCT01697163 | De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors | unknown | — | 155 | Severance HospitalOTHER | 0 | Oct 2, 2012 | clinicaltrials |
| NCT00608868 | SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients(SELINE) | completed | Phase 4 | 156 | AstraZenecaINDUSTRY | 1 | Sep 28, 2012 | clinicaltrials |
| NCT01017133 | Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 1 | 56 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT01688713 | Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer | unknown | Phase 2 | 20 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01687439 | Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | Fudan UniversityOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00991796 | CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 109 | Daiichi SankyoINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT01167972 | Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma(MUTACT) | completed | — | 2,000 | AstraZenecaINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00694603 | Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy | terminated | Phase 2 | 56 | Lecia V. SequistOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01067794 | Chemotherapy in Treating Patients With Lung Cancer(FRAME) | completed | — | 1,610 | Eli Lilly and CompanyINDUSTRY | 0 | Aug 24, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00093132 | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | terminated | Phase 1 / Phase 2 | 20 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00085839 | Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 | completed | Phase 2 | 103 | OSI PharmaceuticalsINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00294762 | Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | completed | Phase 2 | 143 | OSI PharmaceuticalsINDUSTRY | 2 | Aug 9, 2012 | clinicaltrials |
| NCT00386555 | A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. | withdrawn | Phase 2 | 0 | Arog Pharmaceuticals, Inc.INDUSTRY | 0 | Aug 9, 2012 | clinicaltrials |
| NCT00680940 | A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 221 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00048087 | Iressa/Docetaxel in Non-Small-Cell Lung Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors(DIPROCOL) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT01373463 | Cisplatin and Pemetrexed With Radiation Followed by Lobectomy(CisPemXetSrg) | terminated | Phase 1 | 48 | Medical University of South CarolinaOTHER | 1 | Jul 26, 2012 | clinicaltrials |
| NCT00050960 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 612 | Eisai Inc.INDUSTRY | 6 | Jul 13, 2012 | clinicaltrials |
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 159 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT01481259 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jan 9, 2013source: clinicaltrials